Created at Source Raw Value Validated value
Oct. 26, 2020, 11:31 p.m. usa

Neutralizing antibody (Nab assay) response;Safety labs;Specific Th1 cell-mediated immunity (CMI) response;Immediate adverse event (AEs);Serious adverse events (SAEs), adverse events (AEs) leading to withdrawal, adverse event of special interest (AESI) (including vaccine-enhanced disease) and deaths;Specific Th2 cell-mediated immunity (CMI) response;Solicited local and systemic adverse events (AEs);Unsolicited adverse events (AEs)

Neutralizing antibody (Nab assay) response;Safety labs;Specific Th1 cell-mediated immunity (CMI) response;Immediate adverse event (AEs);Serious adverse events (SAEs), adverse events (AEs) leading to withdrawal, adverse event of special interest (AESI) (including vaccine-enhanced disease) and deaths;Specific Th2 cell-mediated immunity (CMI) response;Solicited local and systemic adverse events (AEs);Unsolicited adverse events (AEs)